● Covered by 2 sources · 2 reportsMedium impact2 neutral
Google DeepMind Releases AlphaGenome Atlas for Human Genome Research
Key points
- AlphaGenome Atlas maps every possible DNA letter change.
- It uses the AlphaGenome AI model to predict regulatory impact.
- The dataset is 1 petabyte and includes an AVI score.
- It aids research into non-coding DNA regions.
- The tool aims to accelerate disease treatment development.
Introduction of AlphaGenome Atlas
Google DeepMind has unveiled AlphaGenome Atlas, an AI tool designed to map every possible DNA letter change within the human genome. This platform provides a predictive understanding of how these genetic variations influence molecular biology.
The AlphaGenome Atlas is built upon the AlphaGenome AI model, which pre-calculated the regulatory impact of all 9 billion single-letter genetic changes. This process resulted in a 1-petabyte dataset.
Understanding Genetic Variations
The human genome consists of approximately 3 billion base pairs of DNA. While scientists have a relatively good understanding of the 2% of the genome that codes for proteins, knowledge of the remaining 98% (non-coding DNA regions) is limited. Changes to individual DNA letters can be harmless, contribute to normal human differences, or play a role in disease.
The AlphaGenome Atlas helps address the challenge of identifying which DNA changes are significant and how they function. The AlphaGenome model has previously demonstrated how single changes in non-coding DNA regions can disrupt molecular processes like protein production.
AlphaGenome Variant Impact (AVI) Score
To assist researchers in navigating the extensive data, the Atlas introduces the AlphaGenome Variant Impact (AVI) score. This score combines predictions for both coding and non-coding regions.
The AVI score allows researchers to quickly prioritize promising avenues for genetic research without needing to sift through thousands of data points.
Implications for Research and Treatment
The AlphaGenome Atlas aims to accelerate scientific research by providing a high-resolution map of human DNA. By predicting the effects of single nucleotide variants, the tool can help researchers understand the impact of genetic mutations.
This enhanced understanding is intended to pave the way for the development of new treatments for diseases by clarifying the role of genetic changes.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
The daily brief
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Today's brief
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's brief
New every morning, and the back catalogue is archived by date.
How outlets covered it
Google DeepMind has released AlphaGenome Atlas, a database that predicts the effects of every possible single nucleotide variant in the human genome. This 1-petabyte dataset, generated by the AlphaGenome AI model, provides an AlphaGenome Variant Impact (AVI) score to help researchers prioritize genetic research, particularly in non-coding DNA regions.
Google DeepMind has released AlphaGenome Atlas, an AI tool that provides a predictive map of every possible DNA letter change in the human genome. This tool aims to help researchers understand how genetic mutations affect molecular biology and accelerate the development of new disease treatments.